Kopp Family Office, LLC - Q1 2020 holdings

$146 Million is the total value of Kopp Family Office, LLC's 5 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .

 Value Shares↓ Weighting
NEO SellNeoGenomics Inc$128,630,000
-9.2%
4,658,835
-3.8%
88.30%
-2.0%
VCEL BuyVericel Corporation$6,861,000
+295.0%
748,255
+649.8%
4.71%
+326.6%
RTIX SellRTI Surgical Inc.$6,169,000
-39.3%
3,607,699
-2.8%
4.24%
-34.4%
FIVN BuyFive9, Inc.$2,982,000
+59.3%
38,995
+36.6%
2.05%
+72.0%
XENT BuyIntersect ENT Inc.$1,038,000
-44.4%
87,630
+16.8%
0.71%
-39.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NeoGenomics Inc.16Q3 202390.1%
Vericel Corporation16Q3 202314.5%
Five9, Inc.16Q3 202311.2%
ISHARES TR13Q3 202316.7%
ISHARES TR13Q3 202310.6%
ISHARES TR13Q3 20230.1%
ISHARES TR13Q3 20230.1%
ISHARES TR13Q3 20230.0%
ISHARES TR13Q3 20230.0%
ISHARES TR13Q3 20230.0%

View Kopp Family Office, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Kopp Family Office, LLC Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
RTI Surgical Holdings, Inc.July 07, 2020? ?
NEOGENOMICS INCJanuary 07, 20204,844,6254.6%
OCLARO, INC.January 04, 2019? ?
SUPERCONDUCTOR TECHNOLOGIES INCOctober 05, 2018? ?

View Kopp Family Office, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-16
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-16

View Kopp Family Office, LLC's complete filings history.

Compare quarters

Export Kopp Family Office, LLC's holdings